Welcome Back

Google icon Sign in with Google
OR
I agree to abide by Pharmadaily Terms of Service and its Privacy Policy

Create Account

Google icon Sign up with Google
OR
By signing up, you agree to our Terms of Service and Privacy Policy
Instagram
youtube
Facebook

Medical Writer Ii (Manuscripts/Abstracts)

Syneos Health
Syneos Health
2-5 years
Not Disclosed
10 Jan. 20, 2026
Job Description
Job Type: Full Time Hybrid Education: B.Sc/M.Sc/M.Pharma/B.Pharma/Life Sciences Skills: Causality Assessment, Clinical SAS Programming, Communication Skills, CPC Certified, GCP guidelines, ICD-10 CM Codes, CPT-Codes, HCPCS Codes, ICD-10 CM, CPT, HCPCS Coding, ICH guidelines, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Medical Billing, Medical Coding, Medical Terminology, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

Medical Writer II (Manuscripts/Abstracts) – Clinical & Scientific Writing

Company: Syneos Health
Location: Gurugram, India (Hybrid Work Model)
Job ID: 25104733
Job Type: Full-time | Functional Service Provider (FSP) Model
Experience Required: 2–5 years in medical writing or scientific communications
Date Updated: January 8, 2026


Job Overview

Syneos Health is seeking a Medical Writer II to join its global team in Gurugram, India. This role involves authoring, editing, and coordinating high-quality clinical, regulatory, and publication documents, including manuscripts, abstracts, posters, and oral presentations. The ideal candidate will have strong scientific knowledge, excellent writing skills, and the ability to work collaboratively across functional teams in a fast-paced clinical research environment.

This hybrid position offers exposure to global clinical trial operations and medical communications projects within a Functional Service Provider (FSP) or full-service environment.


About Syneos Health

Syneos Health is a global biopharmaceutical solutions organization operating in 110+ countries with over 29,000 employees worldwide. We support innovative therapies and clinical programs across the drug development lifecycle, including 94% of novel FDA-approved drugs and 95% of EMA-authorized products in the last five years.

Our culture emphasizes diversity, inclusion, and continuous learning, ensuring employees have the opportunity to grow professionally while contributing to meaningful clinical outcomes.